Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
作者
Nadeem R. Abu‐Rustum,Catheryn M. Yashar,Sarah Bean,Kristin A. Bradley,Susana M. Campos,Hye Sook Chon,Christina Chu,David E. Cohn,Marta Ann Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter Jonathan Frederick,David K. Gaffney,Ernest Soyoung Han,Warner King Huh,John Robert Lurain,Andrea Mariani,David G. Mutch
Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.